ArticleBlood advances2023

Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms.

Yasuhito Nannya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.